Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

enterovirus

enterovirus is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 5
Pipeline programs 7
News articles 0
Drug details — enterovirus
Class
—
Route
—
Patents
5
Programs
7
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

enterovirus is an FDA-listed pharmaceutical active ingredient.

Key facts

INN enterovirus

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. PRO-EV71CA16-3001 Phase 3 · Sinovac Research and · Hand, Foot, and Mouth Disease（HFMD)
  2. 100U EV71 vaccine with adjuvant Phase 2 · Sinovac Research and · Infection, Viral, Enterovirus
  3. 400 U EV71 vaccine with adjuvant Phase 2 · Sinovac Research and · Infection, Viral, Enterovirus
  4. Low-dose of tetravalent inactivated enterovirus vaccine (Vero cell) Phase 2 · Sinovac Research and · Hand, Foot, and Mouth Disease (HFMD)
  5. PRO-EV71/CA16-1001 Phase 2 · Sinovac Research and · Hand, Foot and Mouth Disease
  6. 100U inactivated Enterovirus Type 71 Vaccine Phase 1 · Sinovac Research and · Hand-foot-mouth Disease
  7. Inactivated Enterovirus Type 71 Vaccine Phase 1 · Sinovac Research and · Infection; Viral, Enterovirus

Related patents

Browse patents

  1. US 11834451

    Compositions and methods for inhibiting virus protein 2C activity and for preventing and treating non-polio enterovirus infection

    Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10555997

    Antigens and vaccines directed against human enteroviruses

    Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10548964

    Antigens and vaccines directed against human enteroviruses

    Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9987350

    Antigens and vaccines directed against human enteroviruses

    Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8524676

    Method for treating enterovirus or rhinovirus infection using antisense antiviral compounds

    Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is enterovirus?

enterovirus is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.